Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 20Unknown 7Recruiting 7Terminated 3Active not recruiting 2Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Pancreatic Neoplasms 9Carcinoma, Non-Small-Cell Lung 7Rectal Neoplasms 6Colorectal Neoplasms 6Breast Neoplasms 6Neoplasms 5Glioblastoma 5Squamous Cell Carcinoma of Head and Neck 4Ovarian Neoplasms 4Head and Neck Neoplasms 4Stomach Neoplasms 3Oligodendroglioma 3Mouth Neoplasms 3Lung Neoplasms 3Glioma 3Esophageal Neoplasms 3Astrocytoma 3Urinary Bladder Neoplasms 2Sarcoma 2Neoplasm Metastasis 2Meningioma 2Melanoma 2Gliosarcoma 2Glioma, Subependymal 2Fallopian Tube Neoplasms 2Ependymoma 2Carcinoma, Squamous Cell 2Carcinoma, Ovarian Epithelial 2Adenocarcinoma Of Esophagus 2Xerostomia 1

Interventions

Fluorouracil 17Cisplatin 17pembrolizumab 12Radiotherapy 11Oxaliplatin 10Irinotecan 9Paclitaxel 6Leucovorin 6Docetaxel 6Carboplatin 6Capecitabine 6Neoadjuvant Therapy 5Trastuzumab 4Panitumumab 4Gefitinib 4Esophagectomy 4Cyclophosphamide 4Cetuximab 4Surgical Procedures, Operative 3Celecoxib 3tegafur-gimeracil-oteracil 2spartalizumab 2sodium glycididazole 2niraparib 2fludarabine 2S 1 (combination) 2Plicamycin 2Pemetrexed 2Lapatinib 2Gemcitabine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Esophageal Neoplasms × Surgical Procedures, Operative × Clear all
NCT00551759 2023-07-03

Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer

Eastern Cooperative Oncology Group

Phase 2 Terminated
22 enrolled 5 charts
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Neoplasms

NCT00848783 2018-01-08

Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Floxuridine, Followed by Capecitabine for Stomach and Gastro-esophageal Junction (GEJ) Cancers

NYU Langone Health

Phase 2 Terminated
8 enrolled 9 charts
Gastrointestinal

Esophageal Neoplasms, Stomach Neoplasms

NCT00258297 2013-10-16

Gefitinib in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer That Can Be Removed By Surgery

University of Rochester

Phase 2 Terminated
30 enrolled
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡